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The population structure of Staphylococcus aureus carried by healthy humans was determined using a large 
strain collection of nonclinical origin (n = 829). High-throughput amplified fragment length polymorphism 
(AFLP) analysis revealed 3 major and 2 minor genetic clusters of S. aureus, which were corroborated by 
multilocus sequence typing. Major AFLP cluster I comprised 44.4% of the carriage isolates and showed 
additional heterogeneity whereas major AFLP groups II and III presented 2 homogeneous clusters, includ-
ing 47.3% of all carriage isolates. Coanalysis of invasive S. aureus strains and epidemic methicillin-resistant 
S. aureus (MRSA) revealed that all major clusters contained invasive and multiresistant isolates. However, 
clusters and subclusters with overrepresentation of invasive isolates were also identified. Bacteremia in 
elderly adults, for instance, was caused by a IVa cluster–derived strain significantly more often than by 
strains from other AFLP clusters. Furthermore, expansion of multiresistant clones or clones associated 
with skin disease (impetigo) was detected, which suggests that epidemic potential is present in pathogenic 
strains of S. aureus. In addition, the virulence gene encoding Panton-Valentine leukocidin was significantly 
enriched in S. aureus strains causing abscesses and arthritis in comparison with the carriage group. We pro-
vide evidence that essentially any S. aureus genotype carried by humans can transform into a life-threatening 
human pathogen but that certain clones are more virulent than others.
Introduction
Staphylococcus aureus is a major human pathogen capable of caus-
ing a wide range of infections. Over the last 25 years, the incidence 
of both community-acquired and hospital-acquired S. aureus infec-
tions has increased (1, 2). It is assumed that most of the infections 
derive from nasal carriage (3–7) with the nose acting as the primary 
ecological reservoir of S. aureus in humans (8).
In order to perform detailed comparative genomics and popula-
tion genetics for a bacterial species, the limited availability of ade-
quate strain collections needs to be resolved. Although the general 
population structure of S. aureus has been studied previously (9–11), 
these studies were biased because of the use of mostly clinical iso-
lates and collections of nosocomial-acquired methicillin-resistant 
S. aureus (MRSA). The population structure of naturally occurring 
methicillin-susceptible S. aureus isolated from the nose of persons 
living in the community has never been described in detail.
There is controversy over whether all strains of S. aureus have 
equal disease-invoking potential or whether invasive disease is 
associated with particularly virulent genotypes. Day et al. had to 
rescind their conclusion that clonal S. aureus strains that are most 
successful in colonizing humans also show increased virulence 
potential (9, 12). They finally concluded that there is no signifi-
cant difference in population structure between S. aureus carriage 
and disease-associated strains. When Peacock et al. focused on the 
presence of putative virulence determinants rather than overall 
genome polymorphism, it was concluded that 7 of these deter-
minants were significantly more present in invasive isolates of 
S. aureus (13). Whether this increased virulence gene density may be 
specific for certain phylogenetic branches or lineages of S. aureus, 
however, remains unclear.
Most recent studies have assessed the population structure of 
S. aureus using multilocus sequence typing (MLST) (9, 14, 15). 
This molecular typing method characterizes bacterial isolates on 
the basis of the sequence of internal fragments of 7 housekeep-
ing genes, representing the stable “core” of the bacterial genome. 
For each gene fragment, the different sequences are translated 
into distinct alleles, and each isolate is defined by the combina-
tion of alleles of the 7 housekeeping loci (the allelic profile or 
sequence type [ST]) (14). In contrast, whole genome typing meth-
ods, including amplified fragment length polymorphism (AFLP) 
(16, 17), document the contribution of accessory genetic ele-
ments as well as genome-core polymorphisms. AFLP is a meth-
od that scans for polymorphism in actual restriction sites but 
also among the nucleotides bordering these sites. As such, it 
documents nucleotide sequence variation, insertions, and dele-
tions across genomes (16). This may be a more comprehensive 
approach for coming to a full understanding of staphylococcal 
genome diversity and evolution.
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We collected over 2,000 nonclinical S. aureus isolates from vari-
ous groups of healthy individuals in the Dutch community over 
an extended period of time, creating a unique population-based 
strain collection. To assess differences in the virulence potential 
of various strains of S. aureus, insight into the natural (nonclini-
cal) population structure is essential. We here present whole 
genome scanning by high-throughput AFLP (ht-AFLP) of a ran-
dom selection of these S. aureus strains (n = 829). Strains were 
derived from the anterior nares of healthy children (1–18 years) 
and healthy elderly adults (>55 years) from the Rotterdam area 
(The Netherlands) (18, 19). To investigate genomic differences 
between these carriage strains and invasive isolates, contemporary 
isolates from blood, deep-seated, and soft-tissue infections from 
the same geographical area were included (n = 164). Furthermore, 
a collection of international epidemic MRSA strains (n = 21) (20) 
and S. aureus isolates from Rotterdam children with nonbul-
lous impetigo (n = 40) were included (21). The prevalence of the 
clinically relevant mecA and Panton-Valentine leukocidin (PVL) 
genes was determined for all strains as well.
Results
Genetic diversity of S. aureus. Using the set of 1,056 S. aureus strains, a 
total of 155,232 AFLP fragments were generated, covering 147 dif-
ferent marker fragments per strain. These outcomes are visualized 
in Figure 1. The dendrogram on the left (y axis) reveals bacterial 
clustering. The bar on the right of this figure delineates the pres-
ence of 3 major (I, II, III) and 2 minor (IVa, IVb) branches, as identi-
fied by principal component analysis (PCA) (Figure 2, A and B). 
Unsupervised cluster analysis of the 1,056 strains (Figure 3) clearly 
demonstrates that the AFLP data represent 2 distinct, homogenous 
major clusters (II and III) and, conversely, several other smaller 
subclusters that could be divided into 1 major and 2 minor AFLP 
clusters by PCA (I, IVa, IVb). MLST analysis indeed revealed addi-
tional heterogeneity in AFLP group I, identifying different clonal 
complexes (CCs) [CC5, CC8, CC15 (Figure 4)]. CCs are defined as 
clusters of closely related STs where single differences in the allelic 
profile are tolerated (9). In contrast, AFLP clusters II and III har-
bor single CCs, CC30 and CC45, respectively. These 2 major CCs 
embrace almost half (47.3%) of all carriage isolates. Clusters IVa and 
Figure 1
2D hierarchical clustering of the 1,056 S. aureus strains. The green/red figure represents 155,232 binary outcomes generated by ht-AFLP 
with 147 marker fragments. Marker absence corresponds with green and marker presence with red. The dendrogram on the y axis represents 
the phylogenetic clustering of the 1,056 strains. The dendrogram on the x axis shows the clustering of the 147 AFLP markers, many of which 
segregate in specific groups. These groups are cluster specific, and some of these groups are shown as boxes in the figure (A through G). 
The colored, striped bars on the right represent the distribution of the invasive strains (children and elderly adults), the impetigo isolates, the 
MRSA strains, and the reference strains. The carriage strains (n = 829) are not pointed out separately. In conjunction with PCA 3 major (I, II, III) 
and 2 minor (IVa, IVb) branches were identified; these are represented by the black and white bar on the right of the figure.
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IVb are associated with CC22 and CC121, respectively (Figure 4). 
The unsupervised correlation-analysis showed that minor AFLP 
group IVa also consists of different subclusters (Figure 3).
The horizontal dendrogram in Figure 1 shows the clustering 
of the 147 AFLP markers, many of which segregate in separate 
groups. These groups are cluster specific; some of these are shown 
as boxes A–G (Figure 1). The colored bars on the right represent 
the distribution of the invasive strains (in children and elderly 
adults), the impetigo isolates, the MRSA strains, and the reference 
strains across the dendrogram. The central area of this figure best 
defines the 5 phylogenetic lineages. The clustered green and red 
boxes show components of genomic diversity within the 5 S. aureus 
subpopulations. The distributions of the carriage isolates as well 
as the invasive isolates are also visualized in Figure 3.
Carriage versus disease-causing strains of S. aureus. Among the S. aureus 
isolates from healthy individuals with nasal carriage, 3 major genetic 
clusters (I, II, III) could be identified, comprising 760 of the 829 (91.7%) 
carriage strains. Two minor clusters (IVa, IVb) embrace the remain-
ing 69 (8.3%) carriage strains. All 5 clusters coherently contain car-
riage strains isolated from children as well as elderly adults (Figure 5). 
The distribution of the pediatric and geriatric strains across the 5 AFLP 
clusters was overlapping (Figure 3). However, healthy children more 
often carried strains from cluster IVa+b than did healthy elderly 
adults (Fisher’s exact test, P < 0.0001), whereas cluster I strains were 
slightly overrepresented in elderly adults (Fisher’s exact test, P = 0.03). 
Although carriage isolates from children and elderly adults were 
equally divided in AFLP cluster II (Figure 5), a clone strongly associ-
ated with carriage isolates in children could be identified (Fisher’s 
exact test, P < 0.0001) (area between the dotted lines in Figure 3).
Contemporary invasive S. aureus strains (n = 164) from children and 
elderly adults were distributed across all phylogenetic branches and 
widely scattered across the AFLP dendrogram (Figures 1 and 3). The 
population structure of contemporary carriage isolates and invasive 
isolates in the same geographical area appeared to be strongly over-
lapping (Figure 5). However, bacteremia in elderly adults was signifi-
cantly more often caused by a IVa cluster–derived strain (Fisher’s 
exact test, P = 0.0095). Additional analysis of AFLP cluster IVa showed 
that this group consists of distinct subclusters (Figure 3). Therefore 
it would be incorrect to define this minor cluster as a single invasive 
clone. Apparently, several subclusters, plotted next to each other by 3D 
(AFLP cluster IVa), contain proportionately more bacteremia isolates 
from elderly adults than carriage isolates from the same group. Sta-
tistical analysis of major cluster I revealed 2 subclusters potentially 
associated with invasive disease. Subcluster If (Figure 3) contains pro-
portionately more bacteremia isolates from elderly adults (n = 5; 5.6%) 
in comparison with carriage isolates from elderly adults (n = 6; 1.4%) 
(Fisher’s exact test, P = 0.027). Subcluster Ia shows overrepresentation 
of invasive isolates from both children and elderly adults (n = 11; 6.7%) 
in comparison with carriage isolates from both groups (n = 20; 2.4%) 
(Fisher’s exact test; P = 0.01) (Figure 3).
The invasive strains from children in major cluster I are associat-
ed with hospital-acquired disease (Fisher’s exact test, P = 0.01) (data 
not shown). No significant difference was found in the distribution 
of isolates from individuals with invasive community-acquired dis-
ease versus invasive hospital-acquired disease in the other clusters.
All 5 clusters contain S. aureus strains isolated from children with 
community-acquired nonbullous impetigo. The distribution is 
shown in Figures 1 and 5. Compared to pediatric carriage strains, 
Figure 2
PCA of the 1,056 S. aureus strains. The different cubes (plotted in 3D space), colored according to the source, represent every strain in the study. 
Each axis represents the score calculated for that strain on each PC. The distribution of the strains is shown from 2 different angles (A and B). 
The 5 circles indicate the different phylogenetic AFLP clusters.
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impetigo isolates were more frequently found in cluster IVb 
(Fisher’s exact test, P < 0.0001) and less frequently in cluster II 
(Fisher’s exact test, P = 0.01) (Figure 5), suggesting clonal expan-
sion of a certain genotype associated with impetigo (22).
MecA- and PVL-positive strains. The 21 international epidemic MRSA 
strains are present in several clusters and subclusters of S. aureus 
(Ic, Id, Ij, II, III, IVa). This strain collection comprises epidemic 
MRSA from Belgium, Finland, France, Greece, Spain, Germany, 
and the United Kingdom (20). AFLP cluster I contained dispropor-
tionately more MRSA isolates as compared to the other clusters 
(Fisher’s exact test, P = 0.006) (Figure 5), suggesting that many of these 
epidemic MRSA strains are derived from a common cluster I ances-
tor. Notably, most of the 21 MRSA strains are located in subcluster Ic 
(n = 9; 42,9%; Fisher’s exact test, P < 0.0001)].
None of the Dutch carriage and clinical S. aureus isolates (n = 1033) 
included in this study harbor the mecA gene, which is consistent with 
the reported low MRSA prevalence in the Dutch population (23). 
Four PVL-positive S. aureus strains (1.0%) were found in the pediatric 
carriage group (n = 400) and 1 (0.2%) in the elderly adults carriage 
group (n = 429). Three of 146 (2.1%) blood-culture isolates carried 
the PVL gene, 2 of which derived from pediatric patients. Seven of 
the 18 (38.9%) invasive strains isolated from deep-seated or soft-tis-
sue infections in children were PVL positive. There was no signifi-
cant difference in the presence of PVL when comparing the carriage 
isolates and invasive blood-culture isolates. In contrast, S. aureus 
strains causing abscesses and arthritis were significantly enriched 
in the presence of PVL (38.9%) in comparison with the pediatric car-
riage group (1.0%) (Fisher’s exact test, P < 0.0001) and in compari-
son with the pediatric bacteremia isolates (3.6%) (Fisher’s exact test, 
P = 0.0005). All impetigo strains (n = 40) were PVL negative.
Sequence assessment of AFLP markers. To determine the origin of 
genetic polymorphism, the nucleotide sequence of a set of 81 AFLP 
markers was established, 60 of which were located in cluster-specif-
ic marker boxes (Figure 1, boxes A–G). Nineteen of the remaining 
21 markers were not cluster specific and were present in almost all 
1,056 S. aureus strains (red area on the right side of box G, Figure 1). 
Interestingly, 66 (81.5%) of the 81 markers showed homology to all 
3 completed (MW2, Mu50, N315) and 4 unfinished (252, 476, COL, 
NCTC 8325) genome sequences of S. aureus. Conversely, 7 (8.6%) 
of the 81 markers appear to be absent in all 3 completed genomes 
(MW2, Mu50, N315) of S. aureus (see Supplemental Table 1; 
supplemental material available at http://www.jci.org/cgi/content/
full/114/12/1732/DC1). Of these 7 marker fragments, 3 showed 
homology to the S. aureus strain 252 epidemic MRSA-16 (EMRSA-16), 
1 to bacteriophage Φ exfoliative toxin A (ETA) DNA, and 1 to S. 
aureus TY4 exfoliative toxin B (ETB) plasmid DNA. Only 2 did 
not match with any GenBank entry and may represent novel (or 
hypermutable) S. aureus genome segments. The 15 markers that 
Figure 3
Cluster analysis of the 1,056 S. aureus strains using OmniViz. The cells in the correlation visualization are colored by Pearson’s correlation coef-
ficient values with deeper colors indicating higher positive (red) or negative (blue) correlations. The scale bar (underneath the figure) indicates 
100% correlation (red) toward 100% anticorrelation (blue). In order to reveal correlation patterns, a matrix-ordering method was applied to rear-
range the samples. The OmniViz correlation view generated with 1,056 strains was adapted so that descriptive (clinical) parameters could be 
plotted directly adjacent to the original diagonal. The black and white bar on the left indicates the 5 AFLP groups based on PCA. This figure shows 
additional subclustering in major group I (a–j) as well as in minor group IVa, indicated by several lines. The dotted lines identify blocks of minimal 
changes in 1 cluster or subcluster. The corresponding MLST data (see also Figure 4) are shown on the right side of the figure. The distributions of 
the strains from different origins are visualized as red lines in the diagonal red and green bars of the figure (numbered 2–9). Variable 1 indicates 
the different AFLP clusters based on PCA; 2, carriage isolates, children (n = 400); 3, carriage isolates, elderly adults (n = 429); 4, invasive isolates, 
total (n = 164); 5, invasive isolates, children (n = 74); 6, invasive isolates, elderly adults (n = 90); 7, invasive isolates, children (deep-seated and 
soft-tissue infections) (n = 18); 8, impetigo isolates (n = 40); 9, MRSA (n = 21).
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appear to be absent in at least 1 of the known genome sequences of 
S. aureus may be associated with (larger) deletions, the existence of 
which has been described before (24).
The cluster-specific marker boxes are associated with differ-
ent AFLP clusters. Box A is associated with a part of cluster IVa, 
B with cluster IVb, C (present) and G (absent) with cluster III, 
D (present) and F (absent) with cluster II, and box E with cluster I 
(Figure 1). The majority (78.0%) of the markers present in boxes A–D 
(not present in cluster I) showed homology to the reference strains 
Mu50 and N315, which are located in AFLP cluster I. This sug-
gests that these markers become cluster specific by point muta-
tions rather than genomic rearrangement (deletions or insertions). 
This is also supported by additional data (Supplemental Figure 1), 
which show that cluster-defining markers in each box are widely 
spread across the S. aureus chromosome.
Cluster-specific box B, associated with cluster IVb (with 
overrepresentation of impetigo-isolates), comprises both viru-
lence genes bacteriophage Φ ETA DNA and ETB plasmid DNA 
(Supplemental Table 1).
Discussion
The incidence of S. aureus bacteremia is rising and has more than 
doubled over the past 25 years in some Western European coun-
tries. This increase coincides with a growing rate of community-
acquired disease (in proportion to hospital-acquired disease) and 
the epidemic emergence of nosocomial MRSA strains (2). Elderly 
adults are most frequently affected, particularly those with addi-
tional predisposing risk factors. Although a part of this effect 
may be explained by host susceptibility and population aging, 
this does not fully explain the current and drastic rise in the 
number of infections. However, little is known about possible 
bacterial determinants and whether or not these are associated 
with changes in the virulence of S. aureus.
We previously showed that AFLP analysis using optimal enzyme 
and primer combinations is an excellent tool for assessing genetic 
polymorphism in the clonal microorganism M. tuberculosis (17). For 
S. aureus we used the enzyme combination MboI-Csp6I, which resulted 
in a fingerprint of about 70 polymorphic AFLP fragments well distrib-
uted within the size range of 100 bp to 600 bp in a single AFLP reac-
tion. However, a potential limitation of this AFLP approach is in the 
randomness of the restriction sites for MboI and Csp6I. For instance, 
genomic islands with underrepresentation of these restriction sites 
will not be fully scanned for polymorphism. However, if currently 
known genomic sequences of S. aureus (Mu50 and N315) are analyzed 
by computer for the occurrence of these sites, the average number of 
fragments (useful for AFLP) generated per genome is 4.373, and the 
average length of the fragments is 200 bp. This suggests that coverage 
is indeed random and, in this respect, AFLP provides more of a whole 
genome–scanning approach than MLST, for instance.
In the present study, the population structure of S. aureus, iso-
lated from the nose of healthy individuals in the Rotterdam area 
(The Netherlands), has been determined. Using ht-AFLP, we ana-
lyzed 147 polymorphic markers for 1,056 S. aureus strains. Two large 
unbiased strain collections of a nonclinical origin were used. These 
collections were obtained from children (<19 years) and elderly 
adults (>55 years) with nasal carriage of S. aureus. ht-AFLP analysis 
revealed the existence of 3 major (I, II, III) and 2 minor (IVa, IVb) 
phylogenetic branches. Major AFLP group I could be subdivided 
into 10 different subclusters, indicating its heterogeneity. In con-
trast, major clusters II and III showed a very homogenous nature.
Carriage isolates were not completely randomly distributed over 
these clusters. AFLP cluster IVa+b represents more carriage strains 
from children (isolated in 2002) than carriage strains from elderly 
adults (isolated from 1997–1999). A clonal expansion associated 
with carriage isolates in children was also observed in AFLP group 
II. Conversely, AFLP group I embraces more carriage strains from 
elderly adults. Apparently, a certain degree of bacterial popula-
tion heterogeneity exists between the 2 groups included. Whether 
the different sampling moments or the different age categories 
are fundamental to the observed differences is currently unclear. 
Danish studies from the late 1970s demonstrated that waves of 
phage types of S. aureus go through human populations (25, 26). 
Such a phenomenon may explain our current observations. How-
ever, the proportionate distribution of the major phylogenetic 
branches (I, II, III) within the overall population of S. aureus, iso-
lated from humans, appears to be fairly stable over time and com-
parable for children and elderly adults.
Figure 4
AFLP analysis versus MLST analysis of S. aureus. The bar in the 
center of the figure represents the 1,056 strains divided into the 
5 phylogenetic AFLP clusters (similar to those defined at the right 
side of Figure 1). MLST data is shown for 77 S. aureus strains, which 
are spread over the different AFLP clusters. The order of the MLST 
sequence types in this figure is determined by the location of the strain 
in the AFLP dendrogram (Figure 1). *Unknown ST; **6 of the 7 loci are 
similar to the particular ST; ***data not available.
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The 5 AFLP clusters identified in this study match with the major 
CCs as defined by MLST (http://www.mlst.net/). These MLST-based 
CCs have been defined by studying carriage, invasive, and MRSA iso-
lates mainly from the United Kingdom. The top 5 CCs in the MLST 
database are CC8, CC30, CC5, CC22, and CC45 (9, 15, 27, 28). 
We studied more than 1,000 strains isolated in the Rotterdam 
region (The Netherlands), and we identified essentially the same 
CCs. Apparently, these clonal clusters have spread successfully in 
the United Kingdom and The Netherlands and probably worldwide. 
All large-scale molecular typing studies of nonclinical isolates of 
S. aureus have been performed using geographically biased strain col-
lections, including our present analysis. However, considering the 
overlap in MLST types and the similarity in prevalence of certain 
major clonal clusters, it is supposed that geographical bias is not 
a confounding factor. An ongoing analysis of strains derived from 
Indonesian carriers corroborated this hypothesis. The Indonesian 
strains clustered in the same groups (I to IV), although there was 
a difference in the relative numbers of isolates per cluster. No new 
AFLP clusters were identified (Melles et al., unpublished data).
ht-AFLP clusters II and III, identical to MLST CCs 30 and 45, 
respectively, account for almost half (47%) of all carriage isolates 
in our population, which suggests that these 2 CCs have evolved 
to be very successful in colonizing humans.
The above-mentioned observations suggest that virulent and 
nonvirulent strains are probably not fundamentally different from 
each other: clinical isolates and MRSA from international sources 
fall into the same main clusters as carriage isolates. In addition, 
invasive S. aureus strains, mainly blood-culture isolates (89%), were 
found to be widely distributed across all 5 AFLP groups in this 
study. This suggests that strains from each of the genetic clusters 
are essentially able to cause invasive disease. On the other hand, 
1 minor AFLP cluster (IVa) and 2 AFLP subclusters (Ia and 
If) contained proportionately more invasive isolates. Direct 
cross-infection is not a likely explanation for this finding because 
these epidemiologically nonrelated invasive strains were isolated 
from patients in different medical departments over a period of 
several years. There have been controversial reports on the existence 
of hypervirulent lineages of S. aureus (9, 12), but our data suggest 
that not all S. aureus strains share the same invasive potential. This 
is not in agreement with recent findings from the Oxford (United 
Kingdom) region where MLST data suggest that virulence may 
not be associated with clonal lineages (15). Rather, a relationship 
between genetic background and disease type is thought to be pri-
marily dependent on the presence of certain toxin genes only (29).
Figure 5
Distribution of S. aureus strains in the 5 phylogenetic 
branches. *Overrepresentation of carriage in elderly adults 
(Fisher’s exact test, P = 0.01); **overrepresentation of 
carriage in children (Fisher’s exact test, P < 0.0001); 
***proportionately more bacteremia-associated strains from 
elderly adults as compared to carriage strains from the 
same group (3% vs. 10%; Fisher’s exact test, P = 0.0095); 
†proportionately fewer impetigo-associated strains as com-
pared to carriage in children (8% vs. 26%; Fisher’s exact 
test, P = 0.01); ††overrepresentation of impetigo-associated 
strains as compared to carriage in children (38% vs. 5%; 
Fisher’s exact test, P < 0.0001); ‡proportionately more 
MRSA strains as compared to all carriage isolates 
(76% vs. 44%; Fisher’s exact test, P < 0.006).
Table 1
Number of Staphylococcus aureus strains included in this study
 Children  Elderly  Total  
 (n) adults (n) (n)
Carriage 400 429 829
Invasive — blood culture
Hospital acquired 43 68 111
Community acquired 13 22 35
Invasive — deep-seated or soft-tissue infection
Hospital acquired 4 – 4
Community acquired 12 – 12
Unknown 2 – 2
Impetigo 40 – 40
MRSA – – 21
Reference strains – – 2
Total 514 519 1056
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S. aureus strains isolated in the Rotterdam area from patients 
with nonbullous impetigo showed less clonal diversity than bac-
teremia-associated strains. Although each of the 5 clusters was 
found to contain impetigo-derived isolates, AFLP cluster IVb 
clearly represented significantly more isolates causing impetigo. 
An explanation for this clonal expansion in impetigo could be 
the facile spread of this disease. A recent study by Koning et al. 
concerning nonbullous S. aureus impetigo concluded that a combi-
nation of staphylococcal virulence and resistance genes determines 
the development and course of nonbullous impetigo (22).
The 21 international epidemic MRSA strains included in this 
study were spread across several lineages, indicating that methicillin 
resistance has developed in distinct phylogenetic subpopulations 
of S. aureus, which has been described before (10, 30). MLST stud-
ies have placed most of the MRSA in 5 major clusters: CC5, CC8, 
CC22, CC30, and CC45 (10, 27, 31, 32). Figure 4 shows similar dis-
semination for strains from a nonclinical origin as well. Notably, 
computer algorithms used to solve the S. aureus population struc-
ture based on MLST data (eBURST; ref. 28) generate clustering 
identical to that found in the AFLP Spotfire and OmniViz analyses. 
This provides a solid experimental and mathematical framework 
for all conclusions drawn from our AFLP data.
We have also assessed the prevalence of mecA and the PVL genes 
in the carriage and disease-causing populations of S. aureus. All 
carriage isolates (n = 829) were mecA negative, corroborating data 
showing the insignificant spread of MRSA in the Dutch com-
munity (23). Also, all clinical isolates (n = 204) were mecA nega-
tive, as opposed to proportions of above 10% in many of the other 
European countries, including those sharing borders with The 
Netherlands (33). PVL is a toxin associated with skin infections 
(furuncles), community-acquired MRSA infections, and necrotizing 
pneumonia (31, 34, 35). PVL prevalence in a S. aureus population of 
nonclinical isolates has never been studied accurately. We found a 
very low prevalence of 0.6% in a large (n = 829) carriage collection. In 
this study PVL was carried in 2.1% of blood-culture isolates. How-
ever, a significantly higher prevalence of PVL (38.9%) was found in 
S. aureus strains causing abscesses and arthritis. This is in agree-
ment with the proposed involvement of PVL in severe and invasive 
(soft-tissue) staphylococcal infections (31, 35).
Our sequence analysis for the clustered AFLP markers suggested 
that genetic diversity among clusters is primarily caused by point 
mutation rather than by large-scale deletions or insertions (15). 
Ultimate proof for this hypothesis should be provided by detailed 
physical mapping and large-scale sequencing studies, however. 
Furthermore, we provide indirect proof that 7 genome sequences 
quite accurately represent the genetic potential of S. aureus as a 
species; only 4 of 81 marker sequences did not match with the 
7 known S. aureus whole genome sequences.
In conclusion, we have solved the population structure of S. aureus 
of nonclinical origin. Three major and 2 minor phylogenetic 
branches were identified in our geographically restricted group. 
Inclusion of invasive S. aureus strains and international-epidemic 
MRSA revealed that within all major clusters, invasive and multire-
sistant isolates could be identified. However, clusters and subclus-
ters with overrepresentation of bacteremia-associated isolates were 
identified. Expansion of multiresistant clones or clones associated 
with skin disease (impetigo) was observed as well. We suggest that 
essentially any S. aureus genotype that is carried by humans can 
transform into a life-threatening human pathogen, but strains 
from some clonal lineages are more virulent than others.
Methods
Bacterial strains. Two strain collections provided nonclinical S. aureus carriage 
isolates from healthy individuals. These collections were obtained from 2 
study cohorts involving children and elderly adults. In addition, various clin-
ical isolates were included. Contemporary invasive S. aureus strains, isolated 
from children and elderly adults from the same geographic region, were cul-
tured from normally sterile sites in hospitalized patients with clinical signs 
of S. aureus infection. Community-acquired invasive disease was defined as 
isolation of S. aureus from patients within 48 hours of admission; hospital-
acquired was defined as isolation of S. aureus 48 hours or longer after admis-
sion. The different subcollections are described in more detail below.
In total, 3,198 children from Rotterdam (The Netherlands), aged 
between 1 and 19 years and participating in the national 2002 Meningo-
coccal Vaccination Campaign, were enrolled (19). A team of 10 research 
nurses and medical doctors obtained a single nasopharyngeal swab per 
child at the time of vaccination. S. aureus was isolated from 1,116 children. 
All isolates were stored at –80°C in broth containing glycerol. A random 
sample of 400 S. aureus carriage isolates was drawn.
The second collection originated from a community-based prospec-
tive study of elderly adults in Rotterdam (The Netherlands) (18). From 
3,851 persons aged over 55 years, nasal swab cultures were obtained 
between April 1, 1997, and December 31, 1999. S. aureus strains were iso-
lated from 1,043 elderly adults. All isolates were stored at –80°C in glycerol 
containing broth. A random sample of 429 carriage isolates was drawn.
Seventy-four clinical S. aureus isolates were retrospectively collected from 
children with invasive S. aureus disease identified in Sophia Children’s 
University Hospital (Rotterdam, The Netherlands) (2000–2002). Fifty-six 
isolates derived from blood cultures and 18 isolates were obtained from 
deep-seated (arthritis; n = 4) or soft-tissue (abscess; n = 14) infections. 
Ninety clinical isolates from elderly adults (>55 years) were obtained 
from persons with S. aureus bacteremia identified in Erasmus MC 
(Rotterdam, The Netherlands) (1997–1999). Forty S. aureus strains 
obtained from lesions of children suffering from impetigo were randomly 
drawn from a collection described by Koning et al. (21).
Twenty-one international epidemic MRSA strains were obtained from the 
HARMONY collection (http://www.harmony-microbe.net), described by 
Murchan et al. (20). Finally, we included 2 reference strains. N315 is an MRSA 
strain isolated in 1982, and Mu50 is an MRSA strain with reduced susceptibil-
ity to vancomycin isolated in 1997. For both strains genome sequences have 
been determined (36). In total, 1,056 S. aureus strains were included (Table 1).
Cultures, DNA isolation, and detection of mecA and PVL genes. Bacteria were 
grown overnight at 37°C on Columbia III agar (BD) supplemented with 5% 
sheep blood. Three to 5 colonies were suspended in TEG buffer (25 mM Tris, 
10 mM EDTA, 50 mM glucose) containing lysostaphin (50 μg/ml) and 
incubated at 37°C for 1 hour. DNA was extracted with the MagNA Pure LC 
DNA Isolation Kit III (Bacteria, Fungi) using the MagNA Pure LC Instru-
ment (Roche Diagnostics) and stored at –20°C. We determined the pres-
ence of the mecA and PVL genes by PCR (34, 37).
AFLP. AFLP analysis has been performed as described by Van den Braak et al. 
(17). Using the predictive software package Recomb (Keygene NV) (38), the 
optimal enzyme and primer combinations were selected. Bacterial DNA was 
digested with the enzymes MboI and Csp6I, and the linker oligonucleotide pair 
for MboI (5′-CTCGTAGACTGCGTACC-3′ and 5′-GATCGGTACGCAGTC-
TAC-3′) and for Csp6I (5′-GACGATGAGTCCTGAC-3′ and 5′-TAGTCAG-
GACTCAT-3′) were ligated. Subsequently, a nonselective preamplification 
was performed using the MboI primer (5′-GTAGACTGCGTACCGATC-3′) 
and Csp6I primer (5′-GACGATGAGTCCTGACTAC-3′). In the final amplifi-
cation, a 33P-labeled MboI primer containing 1 selective nucleotide (either +C 
or +G) and a Csp6I primer containing 2 selective nucleotides (+TA) were used. 
Amplified material was analyzed using standard polyacrylamide slabgels and 
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subsequent autoradiography. Marker fragments were scored and a binary 
table scoring marker fragment absence (0) or presence (1) was constructed.
After excision of some selected AFLP fragments from dried gels, ream-
plification followed by double-strand sequence analysis was performed 
(17, 38). The sequence of several additional fragments was determined 
by computer analysis. The size of the fragments in combination with the 
selective nucleotides of the AFLP primers facilitated adequate mapping of 
the fragments on the staphylococcal genome sequence. These fragments 
were further analyzed by BLAST searching (http://www.ncbi.nlm.nih.
gov/BLAST/) (39) against the 3 completed (MW2, NC_003923.1; Mu50, 
NC_002758.1; N315, NC_002745.2) and 4 unfinished (252, NC_002952; 
476, NC_002953; COL, NC_002951; NCTC 8325, NC_002954) genomic 
sequences of S. aureus. The BLAST results enabled computer-mediated 
genomic localization and gene annotations of the AFLP fragments.
MLST. MLST was carried out for 56 S. aureus strains using DNA arrays 
(40). The selected strains were equally distributed across the AFLP dendro-
gram by selecting 1 out of 10 carriage or invasive strains isolated from chil-
dren, going from top to bottom through the AFLP dendrogram (Figure 1). 
MLST data for the 21 epidemic MRSA strains are available at the MLST 
home page (http://www.mlst.net/) (20).
Data analysis. The method used for 2D clustering of the AFLP data was 
agglomerative (successive) hierarchical. This was performed using the 
unweighted pair group method with arithmetic mean (UPGMA). The 
similarity metric used was Tanimoto (Spotfire DecisionSite 7.2; Spotfire), 
which defines similarity for binary data (0 and 1) based on the number of 
positive attributes that 2 records have in common. The resulting dendro-
gram was ordered by average value.
PCA is a standard multivariate method used to reduce the dimensional 
space of the data to its principal components (PCs) (41, 42). PCA aims to 
reduce a large number of variables that explain most of the variation in the 
data (43). It is basically a rotation of axes after centering data to the means of 
the variables, the rotated axes being the PCs, which are linear combinations of 
the original variables. The PC computation is displayed as a 3D scatter plot in 
which the position along the axes shows the PCA score of the strain. PCA was 
used to identify subgroups of AFLP clusters as hidden by 2D representation 
of hierarchical clustering. The distribution of the strains in the 5 phylogenetic 
branches was defined on the basis of PCA. Hierarchical cluster analysis and 
PCA were performed using Spotfire DecisionSite 7.2 software.
The OmniViz package (OmniViz Inc.) was used to perform and visual-
ize the results of unsupervised cluster analysis in a correlation visualiza-
tion. This correlation visualization tool displays pairwise correlations 
among the samples calculated by Pearson’s correlation coefficient (44). 
In order to reveal correlation patterns, a matrix-ordering method is 
applied to rearrange the samples. The ordering algorithm starts with the 
most correlated sample pair and, through an iterative process, sorts all 
the samples into correlated blocks. Each sample is joined to a block in 
an ordered manner so that a correlation trend is formed within a block 
with the most correlated samples at the center. The blocks are then posi-
tioned along the diagonal of the plot in a similar ordered manner. As the 
resultant visualization is symmetrical about the diagonal, half the matrix 
display is replaced by appropriate clinical data.
To compare the distribution of strain categories in different 
phylogenetic lineages, Fisher’s exact test was used. A 2-sided P value of 
less than 0.05 was considered significant.
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